Sottorasibu Indian version

Sotoracib (AMG510)is indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer(NSCLC) who have received at least one previous systemic therapy.

There are original drugs and generic drugs of Sotoracib. Currently, the original drugs have European and American versions. The retail price of the European version is about 40,000 to 50,000 yuan a month, and the retail price of the American version is about 60,000 to 70,000 yuan a month. There are many versions of generic drugs. The only generic drugs that are officially marketed are the Lao version and the Bangladeshi version. There is no officially marketed version in India. Four boxes of generic drugs are required per month, and the monthly cost is about 10,000 to 15,000. Currently, pharmaceutical companies that produce the officially marketed versions include Everest, Ziska, ASEAN, Lucius and other pharmaceutical companies. Different pharmaceutical companies have different pricing. The officially marketed versions have the same drug ingredients and dosage specifications. Patients can choose the version according to their own financial situation.

The most common adverse reactions (≥ 20%) with sotorasiib were diarrhea, musculoskeletal pain, nausea, fatigue, hepatotoxicity, and cough. The most common laboratory abnormalities(≥ 25%)are lymphopenia, decreased hemoglobin, increased aspartate aminotransferase, increased alanine aminotransferase, decreased calcium, increased alkaline phosphatase, increased urinary protein, and decreased sodium. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.